Jumpstart Bio: The Future of Drug Pricing

Goodwin's Jumpstart Bio breakfast series gathers leaders in the Boston biotech and pharmaceutical community to discuss the intersection of science, business, and the law. This series equips drug development and commercialization professionals to anticipate, prepare for, and respond to issues on the horizon for the industry. Please join us for Jumpstart Bio's inaugural event, The Future of Drug Pricing. Pharmaceutical drug pricing is at the top of the news cycle and increasingly targeted by Congressional investigations and private and state-sponsored lawsuits. Our panel discussion will focus on crucial pricing issues faced by biotech professionals:

• What is the future of value-based pricing? 
• How are companies using combination pricing for cutting-edge therapeutics? 
• How are political inquiries into drug pricing and related private lawsuits impacting the industry?

Panelists:

• Matthew Connell
          Senior Vice President for Pharmacy + Consumer Solutions, Blue Cross Blue Shield of Massachusetts
• Robert Coughlin
  President + CEO, Massachusetts Biotechnology Council
• Christopher Holding
          Co-chair + Partner, Antitrust + Competition, Goodwin